-
公开(公告)号:US08349839B2
公开(公告)日:2013-01-08
申请号:US12756276
申请日:2010-04-08
申请人: Claudio Sturino , Patrick Deroy , Martin Duplessis , Paul J. Edwards , Anne-Marie Faucher , Teddy Halmos , Clint James , Jean-Eric Lacoste , Eric Malenfant , Joannie Minville , Louis Morency , Sebastien Morin , Martin Tremblay , Christiane Yoakim
发明人: Claudio Sturino , Patrick Deroy , Martin Duplessis , Paul J. Edwards , Anne-Marie Faucher , Teddy Halmos , Clint James , Jean-Eric Lacoste , Eric Malenfant , Joannie Minville , Louis Morency , Sebastien Morin , Martin Tremblay , Christiane Yoakim
IPC分类号: A61K31/501 , A61K31/34 , C07D237/36 , C07D307/92
CPC分类号: C07D491/048 , C07D487/04 , C07D491/147 , C07D513/04 , C07D519/00
摘要: Compounds of formula (I): wherein R1, R2, A1, A2, A3, A4, X and Y are as defined herein, are useful as inhibitors of HIV replication.
摘要翻译: 式(I)化合物:其中R1,R2,A1,A2,A3,A4,X和Y如本文所定义,可用作HIV复制的抑制剂。
-
公开(公告)号:US20150011531A1
公开(公告)日:2015-01-08
申请号:US14366421
申请日:2012-12-19
申请人: Claudio Sturino , Pierre Beaulieu , Patrick Deroy , Martin Duplessis , Clint James , Jean-Eric Lacoste , Joannie Minville , Louis Morency , Sébastien Morin , Bruno Simoneau , Martin Tremblay
发明人: Claudio Sturino , Pierre Beaulieu , Patrick Deroy , Martin Duplessis , Clint James , Jean-Eric Lacoste , Joannie Minville , Louis Morency , Sébastien Morin , Bruno Simoneau , Martin Tremblay
IPC分类号: C07D491/147 , A61K45/06 , A61K31/5377 , A61K31/519 , C07D491/048
CPC分类号: C07D491/147 , A61K31/519 , A61K31/5377 , A61K45/06 , C07D491/048
摘要: Compounds of formula (I) and pharmaceutical compositions thereof: wherein A1 A2 and A3 are each independently selected from the group consisting of N and CR3, wherein R1 is an optionally substituted heterocyclyl or an optionally substituted —(C1-6)alkyl-heterocyclyl, R2 is an optionally substituted aryl or an optionally subsisted heteroaryl, R4 is an optionally substituted aryl, an optionally substituted heterocyclyl or an optionally substituted heteroaryl, useful as an inhibitor of HIV replication.
摘要翻译: 式(I)化合物及其药物组合物:其中A1 A2和A3各自独立地选自N和CR 3,其中R 1是任选取代的杂环基或任选取代的 - (C 1-6)烷基 - 杂环基, R 2是任选取代的芳基或任选取代的杂芳基,R 4是任选取代的芳基,任选取代的杂环基或任选取代的杂芳基,其可用作HIV复制的抑制剂。
-
公开(公告)号:US20100069353A1
公开(公告)日:2010-03-18
申请号:US12517310
申请日:2007-12-03
申请人: Christiane Yoakim , Patrick Deroy , Martin Duplessis , Alexandre Gagnon , Sylvie Goulet , Oliver Huecke , Christopher Lemke , Simon Surprenant
发明人: Christiane Yoakim , Patrick Deroy , Martin Duplessis , Alexandre Gagnon , Sylvie Goulet , Oliver Huecke , Christopher Lemke , Simon Surprenant
IPC分类号: A61K31/397 , C07D401/14 , A61K31/4439 , C07D403/02 , A61K31/4184 , C07D413/14 , A61K31/5377 , C07D403/14 , A61K31/496 , A61P31/18
CPC分类号: C07D409/14 , C07D405/14 , C07D413/14 , C07D417/14
摘要: The present invention relates to compounds of formula (I) wherein R1, R2, R3 and R4 are as defined herein, compositions and uses thereof for treating human immunodeficiency virus (HIV) infection. In particular, the present invention provides novel inhibitors of HIV replication, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HIV infection.
摘要翻译: 本发明涉及其中R 1,R 2,R 3和R 4如本文所定义的式(I)化合物,其用于治疗人类免疫缺陷病毒(HIV)感染的组合物和用途。 特别地,本发明提供HIV复制的新型抑制剂,含有这些化合物的药物组合物和使用这些化合物治疗HIV感染的方法。
-
公开(公告)号:US20100261714A1
公开(公告)日:2010-10-14
申请号:US12756276
申请日:2010-04-08
申请人: Claudio STURINO , Patrick DEROY , Martin DUPLESSIS , Paul J. EDWARDS , Anne-Marie FAUCHER , Teddy HALMOS , Clint JAMES , Jean-Eric LACOSTE , Eric MALENFANT , Joannie MINVILLE , Louis MORENCY , Sebastien MORIN , Martin TREMBLAY , Christiane YOAKIM
发明人: Claudio STURINO , Patrick DEROY , Martin DUPLESSIS , Paul J. EDWARDS , Anne-Marie FAUCHER , Teddy HALMOS , Clint JAMES , Jean-Eric LACOSTE , Eric MALENFANT , Joannie MINVILLE , Louis MORENCY , Sebastien MORIN , Martin TREMBLAY , Christiane YOAKIM
IPC分类号: A61K31/519 , C07D491/048 , C07D413/14 , A61K31/5377 , A61K31/496 , C07D495/04 , A61K31/542 , A61P31/18 , A61K31/497
CPC分类号: C07D491/048 , C07D487/04 , C07D491/147 , C07D513/04 , C07D519/00
摘要: Compounds of formula (I): wherein R1, R2, A1, A2, A3, A4, X and Y are as defined herein, are useful as inhibitors of HIV replication.
摘要翻译: 式(I)化合物:其中R1,R2,A1,A2,A3,A4,X和Y如本文所定义,可用作HIV复制的抑制剂。
-
公开(公告)号:US07300948B2
公开(公告)日:2007-11-27
申请号:US11238732
申请日:2005-09-29
申请人: Pierre Bonneau , Patrick Deroy , Alexandre Gagnon , Jeffrey O′Meara , Bruno Simoneau , Christiane Yoakim
发明人: Pierre Bonneau , Patrick Deroy , Alexandre Gagnon , Jeffrey O′Meara , Bruno Simoneau , Christiane Yoakim
IPC分类号: C07D401/02 , C07D213/02 , A61K31/44
CPC分类号: C07C235/24 , C07C235/84 , C07C237/10 , C07C237/24 , C07C255/56 , C07C2601/02 , C07C2601/04 , C07D205/04 , C07D207/10 , C07D207/16 , C07D211/62 , C07D213/75 , C07D213/81 , C07D213/82 , C07D213/89 , C07D295/088 , C07D295/15 , C07D295/32 , C07D307/33
摘要: Inhibitors of HIV reverse transcriptase which are useful for the treatment of HIV infection. Exemplars of the invention are compounds of the formula wherein the substituents are as defined in the following table R1R2R4R5R8a FCF3MeH—OH FCF3ClH—OH FCF3MeH—O—CH2CO2H ClCNClH—OH.
-
公开(公告)号:US08198458B2
公开(公告)日:2012-06-12
申请号:US12364551
申请日:2009-02-03
申请人: Patrick DeRoy , Anne-Marie Faucher , Alexandre Gagnon , Serge R. Landry , Sebastien Morin , Jeffrey O'Meara , Bruno Simoneau , Bounkham Thavonekham , Christiane Yoakim
发明人: Patrick DeRoy , Anne-Marie Faucher , Alexandre Gagnon , Serge R. Landry , Sebastien Morin , Jeffrey O'Meara , Bruno Simoneau , Bounkham Thavonekham , Christiane Yoakim
IPC分类号: A61K31/41 , C07D257/04
CPC分类号: C07D257/04 , A61K31/41 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/495 , A61K31/5377 , A61K31/541 , C07D231/18 , C07D233/84 , C07D249/08 , C07D249/12 , C07D277/36 , C07D285/06 , C07D285/125 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12
摘要: Compounds of formula (I): wherein Ar, X, R1, R2, R3 and R4 are as defined herein. The compounds are useful as reverse transcriptase inhibitors against wild type and single or double mutant strains of HIV.
摘要翻译: 式(I)化合物:其中Ar,X,R 1,R 2,R 3和R 4如本文所定义。 该化合物可用作针对野生型和单突变或双突变株的逆转录酶抑制剂。
-
公开(公告)号:US08039638B2
公开(公告)日:2011-10-18
申请号:US12517310
申请日:2007-12-03
申请人: Christiane Yoakim , Patrick Deroy , Martin Duplessis , Alexandre Gagnon , Sylvie Goulet , Oliver Hucke , Christopher Lemke , Simon Suprenant
发明人: Christiane Yoakim , Patrick Deroy , Martin Duplessis , Alexandre Gagnon , Sylvie Goulet , Oliver Hucke , Christopher Lemke , Simon Suprenant
IPC分类号: A61K31/4184 , C07D403/04
CPC分类号: C07D409/14 , C07D405/14 , C07D413/14 , C07D417/14
摘要: The present invention relates to compounds of formula (I) wherein R1, R2, R3 and R4 are as defined herein, compositions and uses thereof for treating human immunodeficiency virus (HIV) infection. In particular, the present invention provides novel inhibitors of HIV replication, pharmaceutical compositions containing such compounds and methods for using these compounds in the treatment of HIV infection.
摘要翻译: 本发明涉及其中R 1,R 2,R 3和R 4如本文所定义的式(I)化合物,其用于治疗人类免疫缺陷病毒(HIV)感染的组合物和用途。 特别地,本发明提供HIV复制的新型抑制剂,含有这些化合物的药物组合物和使用这些化合物治疗HIV感染的方法。
-
公开(公告)号:US20090143370A1
公开(公告)日:2009-06-04
申请号:US12364551
申请日:2009-02-03
申请人: Patrick DeROY , Anne-Marie FAUCHER , Alexandre GAGNON , Serge LANDRY , Sebastien MORIN , Jeffrey O'MEARA , Bruno SIMONEAU , Bounkham THAVONEKHAM , Christiane YOAKIM
发明人: Patrick DeROY , Anne-Marie FAUCHER , Alexandre GAGNON , Serge LANDRY , Sebastien MORIN , Jeffrey O'MEARA , Bruno SIMONEAU , Bounkham THAVONEKHAM , Christiane YOAKIM
IPC分类号: A61K31/541 , C07D257/04 , A61K31/41 , A61K31/4439 , A61P31/18 , C07D401/12 , C07D417/12
CPC分类号: C07D257/04 , A61K31/41 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/495 , A61K31/5377 , A61K31/541 , C07D231/18 , C07D233/84 , C07D249/08 , C07D249/12 , C07D277/36 , C07D285/06 , C07D285/125 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12
摘要: Compounds of formula (I): wherein Ar, X, R1, R2, R3 and R4 are as defined herein. The compounds are useful as reverse transcriptase inhibitors against wild type and single or double mutant strains of HIV.
摘要翻译: 式(I)化合物:其中Ar,X,R 1,R 2,R 3和R 4如本文所定义。 该化合物可用作针对野生型和单突变或双突变株的逆转录酶抑制剂。
-
9.
公开(公告)号:US20060069261A1
公开(公告)日:2006-03-30
申请号:US11238732
申请日:2005-09-29
申请人: Pierre Bonneau , Patrick Deroy , Alexandre Gagnon , Jeffrey O'Meara , Bruno Simoneau , Christiane Yoakim
发明人: Pierre Bonneau , Patrick Deroy , Alexandre Gagnon , Jeffrey O'Meara , Bruno Simoneau , Christiane Yoakim
IPC分类号: C07D213/72 , C07C255/28
CPC分类号: C07C235/24 , C07C235/84 , C07C237/10 , C07C237/24 , C07C255/56 , C07C2601/02 , C07C2601/04 , C07D205/04 , C07D207/10 , C07D207/16 , C07D211/62 , C07D213/75 , C07D213/81 , C07D213/82 , C07D213/89 , C07D295/088 , C07D295/15 , C07D295/32 , C07D307/33
摘要: Inhibitors of HIV reverse transcriptase which are useful for the treatment of HIV infection. Exemplars of the invention are compounds of the formula wherein the substituents are as defined in the following table. R1R2R4R5R8a FCF3MeH—OH FCF3ClH—OH FCF3MeH—O—CH2CO2H ClCNClH—OH
摘要翻译: 可用于治疗HIV感染的HIV逆转录酶抑制剂。 本发明的实例是下式的化合物
-
公开(公告)号:US20050282907A1
公开(公告)日:2005-12-22
申请号:US11137831
申请日:2005-05-24
申请人: Patrick Deroy , Anne-Marie Faucher , Alexandre Gagnon , Serge Landry , Sebastien Morin , Jeffrey O'Meara , Bruno Simoneau , Bounkham Thavonekham , Christiane Yoakim
发明人: Patrick Deroy , Anne-Marie Faucher , Alexandre Gagnon , Serge Landry , Sebastien Morin , Jeffrey O'Meara , Bruno Simoneau , Bounkham Thavonekham , Christiane Yoakim
IPC分类号: A61K31/165 , A61K31/41 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/495 , A61K31/5377 , A61K31/541 , A61P31/18 , C07D231/18 , C07D233/84 , C07D249/04 , C07D249/08 , C07D249/10 , C07D249/12 , C07D257/04 , C07D277/36 , C07D285/06 , C07D285/12 , C07D285/125 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12
CPC分类号: C07D257/04 , A61K31/41 , A61K31/4439 , A61K31/454 , A61K31/4709 , A61K31/495 , A61K31/5377 , A61K31/541 , C07D231/18 , C07D233/84 , C07D249/08 , C07D249/12 , C07D277/36 , C07D285/06 , C07D285/125 , C07D401/12 , C07D403/12 , C07D405/12 , C07D409/12 , C07D413/12
摘要: Compounds of formula (I): wherein Ar, X, R1, R2, R3 and R4 are as defined herein. The compounds are useful as reverse transcriptase inhibitors against wild type and single or double mutant strains of HIV.
摘要翻译: 式(I)化合物:其中Ar,X,R 1,R 2,R 3和R 4, >如本文所定义。 该化合物可用作针对野生型和单突变或双突变株的逆转录酶抑制剂。
-
-
-
-
-
-
-
-
-